Women with a diagnosis of breast cancer are cared for by a multidisciplinary team of physician specialists at the Center for Breast Cancer, including radiologists, breast surgeons, medical oncologists, radiation oncologists, pathologists, and plastic surgeons.
The Hematology Program offers the most comprehensive services for the diagnosis and treatment of blood cancers in the region. Patients have access to a disease-based multispecialty team with special interest and clinical expertise treating lymphoma, leukemia, and myeloma. Physicians meet regularly to discuss patient care and to develop a comprehensive treatment plan unique for each patient.
The Gynecologic Oncology Program focuses on the care of women with gynecologic cancers. Women diagnosed with vulvar, vaginal, cervical, uterine, fallopian tube, or ovarian cancers are provided with exceptional care. Gynecologic oncology services unite a multidisciplinary team of clinicians. Our physicians are board-certified in obstetrics and gynecology and in the subspecialty of gynecologic oncology, which brings together surgery, chemotherapy, and radiation oncology.
Patients being cared for by the Prostate and Urologic Cancers Program benefit from the expertise of a collaborative approach to cancer care, which personalizes treatment options for tumors affecting the prostate, bladder, kidney, testes, upper tract (ureter and renal pelvis), penis, and urethra. As part of your care, we engage experts who specialize in medical oncology, radiation oncology, surgical oncology, pathology, and diagnostic imaging.
Multidisciplinary Prostate Cancer Clinic
Overview
The Multidisciplinary Prostate Cancer Program at Smilow Cancer Hospital, located at suite 2400, offers a comprehensive evaluation focused on optimizing clinical care and outcomes for patients with newly diagnosed localized and locally advanced prostate cancer. The program consists of a multidisciplinary team of expert specialists working in collaboration to provide the best personalized treatment plan for each patient.
Our physicians will assess and together discuss the next steps for each patient, including discussing innovative clinical trials that may be available.
Who is at risk for prostate cancer?
Any male born with a prostate is at risk for developing prostate cancer. However, some factors increase the likelihood of getting prostate cancer, including:
- Age: Prostate cancer is not common in men under 40, but the risk of getting it increases quickly after turning 50.
- Race/ethnicity: Prostate cancer occurs more frequently in African American men compared to men of other races.
- Family history: A family history of prostate and other cancers can increase the risk of prostate cancer in an individual.
- Inherited gene changes: Some genetic mutations inherited from parents can increase the risk of prostate cancer.
Multidisciplinary team
Our multidisciplinary team of experts, including urologists, medical oncologists, radiation oncologists, and nuclear medicine specialists as needed, collaborates to develop a customized care plan for every patient.
Who is eligible?
Newly diagnosed prostate cancer patients are eligible to receive a multidisciplinary visit with a urologist, medical oncologist and radiation oncologist. In addition, men with high-risk localized, advanced or oligometastatic prostate cancer, a stage where the cancer has only spread to one or a few sites, are eligible to participate.
Patients will be prescreened for eligibility into the program by a physician. Patients will then be presented to the multidisciplinary team, where a recommendation for a treatment plan will be discussed. Patients may have options for multiple approaches, including robotic prostatectomy, radiation therapy, systemic therapies (e.g., hormone treatments), and clinical trials.
For appointments or referrals, please call 203-863-3700
The Center for Thoracic Cancers coordinates and integrates the diagnosis, evaluation, and treatment of patients diagnosed with a thoracic malignancy, including lung cancer, thymic cancers, mesothelioma, esophageal, or chest wall tumors. Specialties include medical oncology, radiation oncology, thoracic surgery, pulmonary medicine, interventional oncology, pulmonary intervention, pathology, diagnostic imaging, and nursing.
Our patients have access to the Lung Cancer Screening Program which has proven to be a critical tool in providing patients at risk with individualized, evidence-based screening, and helping to detect these cancers earlier.
